| Mrs Barbara D Fischer, CPC, LIMHP, LADC | |
|
2217 W 12th St Ste 4, Hastings, NE 68901-3660 | |
| (402) 469-7271 | |
| (402) 925-6893 |
| Full Name | Mrs Barbara D Fischer |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2217 W 12th St Ste 4, Hastings, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124310800 | NPI | - | NPPES |
| 10026376300 | Medicaid | NE | |
| 1104242874 | Medicaid | NE |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Barbara D Fischer, CPC, LIMHP, LADC 2217 W 12th St Ste 4, Hastings, NE 68901-3660 Ph: (402) 469-7271 | Mrs Barbara D Fischer, CPC, LIMHP, LADC 2217 W 12th St Ste 4, Hastings, NE 68901-3660 Ph: (402) 469-7271 |
News Archive
Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.
Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.
Three researchers from the Dermatology Research Foundation at the University of Sydney have identified a compound produced by certain fatal skin cancer tumours, providing new hope for developing treatments.
"The World Health Organization (WHO) established a global monitoring framework for non-communicable diseases (NCDs) at a Geneva meeting on November 9, 2012 - a little over a year after the U.N. General Assembly adopted a political declaration on NCDs," Management Sciences for Health's "Global Health Impact" blog reports, noting Ambassador Betty King, permanent representative of the U.S. to the U.N. and other international organizations in Geneva, announced the framework in November.
› Verified 9 days ago
Cassandra Mohler, Counselor Medicare: Not Enrolled in Medicare Practice Location: 724 S Burlington Ave, Hastings, NE 68901 Phone: 402-463-7435 Fax: 402-463-0687 | |
Taylor Kindig, Counselor Medicare: Medicare Enrolled Practice Location: 225 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-463-5075 | |
Deneen Jane Denny, AAS,PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 907 S Kansas Ave, Hastings, NE 68901 Phone: 402-462-4677 | |
Amanda M Schroeder, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 835 S Burlington Ave, Suite 108, Hastings, NE 68901 Phone: 402-463-7711 Fax: 402-461-5099 | |
Elizabeth Anne Spencer, MS ED, LIMHP, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 432 N Minnesota Ave, Hastings, NE 68901 Phone: 402-463-1400 Fax: 402-463-1442 | |
Arlene Karr, Counselor Medicare: Not Enrolled in Medicare Practice Location: 724 S Burlington Ave, Hastings, NE 68901 Phone: 402-463-7435 | |
Lindsey Ann Lyons, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 907 S Kansas Ave, Hastings, NE 68901 Phone: 402-462-4677 |